comparemela.com

Latest Breaking News On - Hua medtech - Page 1 : comparemela.com

Penumbra Inc (PEN) Q4 2020 Earnings Call Transcript

Penumbra Inc (PEN) Q4 2020 Earnings Call Transcript Motley Fool Transcribers © The Motley Fool Logo of jester cap with thought bubble. Penumbra Inc (NYSE: PEN) Operator Good afternoon. My name is Chris, and I ll be your conference operator today. At this time, I would like to welcome everyone to Penumbra, Inc. Q4 and Full Year 2020 Earnings Call. [Operator Instructions] Thank you. I would like to introduce Ms. Jee Hamlyn-Harris, Investor Relations for Penumbra. Ms. Hamlyn-Harris, you may begin your conference. This article is a transcript of this conference call produced for The Motley Fool. While we strive for our Foolish Best, there may be errors, omissions, or inaccuracies in this transcript. As with all our articles, The Motley Fool does not assume any responsibility for your use of this content, and we strongly encourage you to do your own research, including listening to the call yourself and reading the company s SEC filings. Please see our

United statesAllen gong jpmorganAdam elsesserBob hopkinsRobbie marcusAsia pacificJoanne wuenschMatt henriksson citiLarry biegelsenMaggie yuenHua medtechJee hamlyn harrisBrandon vazquez william blairMargaret kaczorMatt henrikssonRyan zimmerman

Genesis Medtech Collaborates with Penumbra to Expand Neurovascular Market in China

Genesis Medtech Collaborates with Penumbra to Expand Neurovascular Market in China - Partnership to be in tandem with formation of Genesis Medtech s Neurovascular Franchise, pending an ongoing full acquisition of Hua Medtech - The collaboration will position Genesis MedTech ( Genesis ) as the largest local company in China s neurovascular space News provided by Share this article Share this article SINGAPORE, Jan. 19, 2021 /PRNewswire/ Genesis MedTech Group has reached a consensus to fully acquire Hua Medtech as part of its plans to set up a specialised neurovascular franchise, which has entered into a strategic cooperation with Penumbra, Inc., an NYSE listed, global healthcare company focused on innovative therapies, for the domestic sales and production of products with Penumbra s technology for the Chinese market.

United statesHua medtechWarren wangAdam elsesserPenumbra incGenesis medtech internationalGenesis medtech groupNational medical products administrationPrnewswire genesis medtech groupImedtech groupMinitech medicalChief executive officerஒன்றுபட்டது மாநிலங்களில்ஹுவா மெதிதேச்வாரன் வாங்ஜநெஸிஸ் மெதிதேச் சர்வதேச

vimarsana © 2020. All Rights Reserved.